{
  "resourceType": "Bundle",
  "id": "GeneticRiskReferral_eve-fhxgeneinherited_yes_eve-unkvariantstatus_yes_act-geneticreferral",
  "type": "collection",
  "entry": [
    {
      "fullUrl": "http://cancerscreeningcds.github.io/bcsm-cds/CarePlan/257",
      "resource": {
        "resourceType": "CarePlan",
        "id": "257",
        "subject": {
          "reference": "Patient/defaultPatient",
          "display": "Jane Doe"
        },
        "instantiatesCanonical": [
          "http://cancerscreeningcds.github.io/bcsm-cds/PlanDefinition/flow-GeneticRiskReferral"
        ],
        "intent": "proposal",
        "status": "draft",
        "created": "2023-12-10T00:00:00.0Z",
        "activity": [
          {
            "reference": {
              "reference": "RequestGroup/258"
            }
          }
        ]
      }
    },
    {
      "fullUrl": "http://cancerscreeningcds.github.io/bcsm-cds/RequestGroup/258",
      "resource": {
        "resourceType": "RequestGroup",
        "id": "258",
        "subject": {
          "reference": "Patient/defaultPatient",
          "display": "Jane Doe"
        },
        "instantiatesCanonical": [
          "http://cancerscreeningcds.github.io/bcsm-cds/PlanDefinition/flow-GeneticRiskReferral"
        ],
        "intent": "proposal",
        "status": "draft",
        "action": [
          {
            "id": "GeneticReferralVariant",
            "title": "Referral for genetic risk counseling",
            "description": "Referral for genetic counseling if not previously evaluated for variant of concern based on known family history.\n\nAny blood relative with known BRCA1/BRCA2 variants, Li-Fraumeni syndrome (TP53 variant), Cowden or Bannayan-Riley-Ruvalcaba syndromes (PTEN variants), and other variants known to be associated with increased risk of development of breast cancer. Variants may include ATM, BARD1, CDH1, CHEK2, NF1, PALB2, RAD51C, RAD51D, STK11.",
            "documentation": [
              {
                "type": "citation",
                "label": "USPSTF",
                "display": "BRCA-Related Cancer: Risk Assessment, Genetic Counseling, and Genetic Testing",
                "citation": "US Preventive Services Task Force. Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer: US Preventive Services Task Force Recommendation Statement. JAMA. 2019;322(7):652â€“665.",
                "url": "https://www.uspreventiveservicestaskforce.org/uspstf/recommendation/brca-related-cancer-risk-assessment-genetic-counseling-and-genetic-testing"
              }
            ],
            "resource": {
              "reference": "ServiceRequest/259"
            }
          }
        ]
      }
    },
    {
      "fullUrl": "http://cancerscreeningcds.github.io/bcsm-cds/ServiceRequest/259",
      "resource": {
        "id": "259",
        "resourceType": "ServiceRequest",
        "status": "option",
        "basedOn": [
          {
            "reference": "http://cancerscreeningcds.github.io/bcsm-cds/ActivityDefinition/GeneticCounselingReferralRequest"
          }
        ],
        "subject": {
          "reference": "Patient/defaultPatient",
          "display": "Jane Doe"
        },
        "intent": "proposal",
        "code": {
          "coding": [
            {
              "code": "geneticriskreferral",
              "system": "http://cancerscreeningcds.github.io/bcsm-cds/CodeSystem/plan-definition-action-code-system",
              "display": "Genetic risk referral"
            }
          ]
        },
        "reasonCode": [
          {
            "coding": [
              {
                "code": "fhxgenetic",
                "system": "http://cancerscreeningcds.github.io/bcsm-cds/CodeSystem/plan-definition-action-reason-code-system",
                "display": "Family history of inherited cancer susceptibility"
              }
            ]
          }
        ]
      }
    }
  ]
}